Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Abdullah Illeyyan has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Perspective Chapter: Mental Health Integration in Primary Medical Care

    by Ali Msheik, Nasser Al-Saad, Ruben Peralta, Zeinab Al Mokdad, Abdulla Illeyyan, Amr El Mohamad, Faisal AlShurbaji, Alaaeldin Ahmed, Mazyona Al Maadhadi, Pablo Bauza, et al.

    Mental health integration into primary care is increasingly recognized as a healthcare priority because mental disorders commonly coexist with chronic physical illnesses and can affect clinical outcomes, quality of life, healthcare utilization, and costs. This chapter reviews the principles, implementation strategies, and clinical significance of incorporating mental health services into routine primary care. It examines common conditions encountered in primary care, including depression, anxiety disorders, stress-related disorders, and substance use disorders, and summarizes evidence-informed approaches to screening, assessment, treatment, referral, and follow-up. The chapter also discusses collaborative care models, multidisciplinary teams, and digital mental health technologies that may improve access, continuity, and patient engagement. Major implementation challenges include stigma, healthcare disparities, workforce shortages, organizational barriers, policy limitations, and ethical concerns. Finally, emerging developments in person-centered integrated behavioral healthcare, precision psychiatry, and digital innovation are considered as potential approaches for strengthening comprehensive, accessible, and equitable primary healthcare systems.

  • Open Access

    The Psychological Effects of Exercise: Neurobiological Mechanisms and Clinical Applications

    by Ali Msheik, Ruben Peralta, Zeinab Al Mokdad, Muath Hussein, Abdulla Illeyan, Nasser Alsaad, Fatima Al-Sada, Mazyouna Al-Maadhadi, Amro Al Hajjali, Aisha Alkubaisi, et al.

    Exercise is increasingly recognized as a clinically relevant intervention for mental health, with benefits that extend beyond physical fitness to improve mood, cognition, stress regulation, and overall well-being. This chapter examines the psychological effects of exercise through an integrated framework that links neurobiological mechanisms with clinical applications. Exercise modulates key neurotransmitters, enhances neuroplasticity through brain-derived neurotrophic factor (BDNF), improves cerebral perfusion, regulates the hypothalamic-pituitary-adrenal (HPA) axis, and reduces systemic inflammation. It also promotes behavioral activation, self-efficacy, emotion regulation, sleep quality, and social engagement, all of which contribute to improved psychological health. Clinical evidence supports the use of exercise across a broad spectrum of conditions, including depression, anxiety disorders, stress-related disorders, cognitive decline, and severe mental illness, where it functions as a preventive, adjunctive, and rehabilitative intervention. Successful implementation requires individualized exercise prescription, recognition of patient-specific barriers, and integration within comprehensive mental health care. Although exercise should not replace established pharmacological or psychological treatments, it offers a scalable, cost-effective, and sustainable strategy that complements conventional therapies and supports whole-person care. Future research should focus on personalized exercise prescriptions, optimization of intervention characteristics, and integration with digital health technologies to enhance adherence, accessibility, and long-term mental health outcomes.

  • Open Access

    Validation of the Arabic Version of the Edmonton Symptom Assessment System

    by Omar Shamieh, Ghadeer Alarjeh, Mohammad Al Qadire, Zaid Amin, Abdelrahman AlHawamdeh, Mohammad Al-Omari, Omar Mohtadi, Abdullah Illeyyan, Omar Ayaad, Sawsan Al-Ajarmeh, et al.

    Quality cancer care is a team effort. In addition, patients’ symptoms change over the course of treatment. As such, the Edmonton Symptom Assessment System (ESAS) is a simple tool designed to quickly monitor symptom change. Here, we present the results from a two-phase study aimed at validating the Arabic version of the ESAS (ESAS-A). Phase one involved the creation of two versions of the ESAS with both reverse and forward translations by bilingual, native Arabic speakers as well as evaluation by an expert panel. The reconciled version was then administered to 20 patients as a pilot from which to create the final version, which was then used with 244 patients. Phase two for the ESAS—involved an ESAS-based validation of 244 adults aged 18 years and older who were diagnosed with advanced cancer; then, further validation was completed in conjunction with two other symptom survey tools, the EORTC-Pal 15 and the HADS. The ESAS-A items possessed good internal consistency with an average Cronbach’s alpha of 0.84, ranging from 0.82 to 0.85. Moreover, the results of ESAS-A showed good agreement with those of EORTC QLQ- 15 PAL (r = 0.36 to 0.69) and HADS (r = 0.60 and 0.57) regarding anxiety and depression. We found the ESAS-A to be responsive to symptom change and a median time to completion of 3.73 min. The results of our study demonstrate that the ESAS-A is a reliable, valid, and feasible tool for the purposes of monitoring symptom change over the course of cancer treatment.